✦ LIBER ✦

MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy

✍ Scribed by Consolación Melguizo, Jose Prados, Beatriz González, Raul Ortiz, Angel Concha, Pablo Juan Alvarez, Roberto Madeddu, Gloria Perazzoli, Jaime Antonio Oliver, Rodrigo López, Fernando Rodríguez-Serrano, Antonia Aránega

Book ID: 119905296
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 723 KB
Volume: 10
Category: Article
ISSN: 1479-5876
DOI: 10.1186/1479-5876-10-250

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MGMT Gene Promoter Methylation Status as

MGMT Gene Promoter Methylation Status as a Potent Prognostic Factor in Glioblastoma Treated with Temozolomide Chemo-irradiation

✍ Y. Kim; S. Kim; J. Kim; J. Cho; J. Chang; D. Kim; K. Lee; C. Suh 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Temozolomide concomitant and adjuvant to

Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma : Correlation with MGMT promoter methylation status

✍ Alba A. Brandes; Enrico Franceschi; Alicia Tosoni; Francesca Benevento; Luciano 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Recurrence Pattern After Temozolomide Co

Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation With MGMT Promoter Methylation Status

✍ Brandes, A. A.; Tosoni, A.; Franceschi, E.; Sotti, G.; Frezza, G.; Amista, P.; M 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 461 KB

Methylation status of the MGMT gene prom

Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin

✍ Chul-Kee Park; Sung-Hye Park; Se-Hoon Lee; Chae-Yong Kim; Dong-Wan Kim; Sun Ha P 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Temozolomide and radiotherapy in newly d

Temozolomide and radiotherapy in newly diagnosed glioblastoma patients: O6-methylguanine-DNA methyltransferase (MGMT) promotor methylation status and Ki-67 as biomarkers for survival and response to treatment

✍ Khaled Abdel Karim; M. M. El Mahdy; M. M. Abdel Wahab; L. R. Ezz EI Arab; A. El 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 464 KB